1. Metabolic Enzyme/Protease GPCR/G Protein
  2. Endogenous Metabolite LPL Receptor
  3. Sphingosine-1-phosphate

Sphingosine-1-phosphate  (Synonyms: S1P)

Cat. No.: HY-108496 Purity: 99.0%
Handling Instructions Technical Support

Sphingosine-1-phosphate (S1P) is an agonist of S1P1-5 receptors and a ligand of GPR3, GPR6 and GPR12. Sphingosine-1-phosphate is an intracellular second messenger and mobilizes Ca2+ as an extracellular ligand for G protein-coupled receptors. Sphingosine-1-phosphate is an important lipid mediator generated from Sphingomyelin (HY-113498) or other membrane phospholipids. Sphingosine-1-phosphate stimulates the DNA synthesis, cell proliferation and migration.

For research use only. We do not sell to patients.

CAS No. : 26993-30-6

Size Price Stock Quantity
1 mg In-stock
5 mg Get quote
10 mg Get quote
25 mg Get quote
50 mg Get quote
100 mg Get quote
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 17 publication(s) in Google Scholar

Other Forms of Sphingosine-1-phosphate:

Top Publications Citing Use of Products

    Sphingosine-1-phosphate purchased from MedChemExpress. Usage Cited in: Sci Adv. 2025 Aug 8;11(32):eadw5001.  [Abstract]

    Representative flow cytometric plots and quantitative analysis of mature DCs (CD80+CD86+) gating on CD11c+ cells after treated with different concentrations of S1P (0.5-1.0 μM; 24 h).

    Sphingosine-1-phosphate purchased from MedChemExpress. Usage Cited in: Sci Adv. 2025 Aug 8;11(32):eadw5001.  [Abstract]

    The levels of lactate dehydrogenase (LDH) after coculture of S1P-treated (0.5-1.0 μM; 24 h) BMDMs and LLC cells at radios of 10:1 or 15:1.

    Sphingosine-1-phosphate purchased from MedChemExpress. Usage Cited in: Sci Adv. 2025 Aug 8;11(32):eadw5001.  [Abstract]

    Relative mRNA expression of M1 macrophages marker genes (iNOS, IL-6, IL-1β, and TNF-α) in S1P-treated (0.5-1.0 μM; 24 h) BMDMs.

    Sphingosine-1-phosphate purchased from MedChemExpress. Usage Cited in: Sci Adv. 2025 Aug 8;11(32):eadw5001.  [Abstract]

    Representative images of migratory Raw264.7 cells stained with crystal violet at 18 hours after incubation with S1P (0.5-1.0 μM).

    Sphingosine-1-phosphate purchased from MedChemExpress. Usage Cited in: Sci Adv. 2025 Aug 8;11(32):eadw5001.  [Abstract]

    The levels of p-STAT1, p-p65, and p-IκBα expressed in BMDMs after treated with 1 μM S1P for 15, 30, or 120 min.

    Sphingosine-1-phosphate purchased from MedChemExpress. Usage Cited in: Sci Adv. 2025 Aug 8;11(32):eadw5001.  [Abstract]

    The levels of NLRP3 expressed in BMDMs after treated with 1 μM S1P for 4 or 8 hours.

    Sphingosine-1-phosphate purchased from MedChemExpress. Usage Cited in: Sci Adv. 2025 Aug 8;11(32):eadw5001.  [Abstract]

    Mitochondrial ROS and mitochondria in Raw264.7 were detected by MitoSOX Red staining and TMRM, respectively, and analyzed by confocal microscopy after S1P (1 μM; 24 h) and Mdivi-1 (10 μM) treatment.

    View All Endogenous Metabolite Isoform Specific Products:

    View All LPL Receptor Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Sphingosine-1-phosphate (S1P) is an agonist of S1P1-5 receptors and a ligand of GPR3, GPR6 and GPR12. Sphingosine-1-phosphate is an intracellular second messenger and mobilizes Ca2+ as an extracellular ligand for G protein-coupled receptors[1]. Sphingosine-1-phosphate is an important lipid mediator generated from Sphingomyelin (HY-113498) or other membrane phospholipids[2]. Sphingosine-1-phosphate stimulates the DNA synthesis, cell proliferation and migration[4].

    IC50 & Target

    Human Endogenous Metabolite

     

    Cellular Effect
    Cell Line Type Value Description References
    CHO EC50
    0.2 nM
    Compound: S1P
    Displacement of [33P]S1P from human recombinant S1P5 receptor expressed in CHO cells by scintillation counting
    Displacement of [33P]S1P from human recombinant S1P5 receptor expressed in CHO cells by scintillation counting
    [PMID: 20446681]
    CHO EC50
    0.55 nM
    Compound: sphingosine-P
    Activity at human recombinant S1P1 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
    Activity at human recombinant S1P1 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
    [PMID: 17070046]
    CHO EC50
    0.91 nM
    Compound: sphingosine-P
    Activity at human recombinant S1P5 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
    Activity at human recombinant S1P5 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
    [PMID: 17070046]
    CHO EC50
    1.6 nM
    Compound: sphingosine-P
    Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
    Activity at human recombinant S1P3 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
    [PMID: 17070046]
    CHO EC50
    121 nM
    Compound: S1P
    Agonist activity at human recombinant S1P5 receptor expressed in CHO cells by GTPgammaS binding assay
    Agonist activity at human recombinant S1P5 receptor expressed in CHO cells by GTPgammaS binding assay
    [PMID: 20446681]
    CHO EC50
    164 nM
    Compound: S1P
    Agonist activity at human recombinant S1P4 receptor expressed in CHO cells by GTPgammaS binding assay
    Agonist activity at human recombinant S1P4 receptor expressed in CHO cells by GTPgammaS binding assay
    [PMID: 20446681]
    CHO EC50
    7.9 nM
    Compound: sphingosine-P
    Activity at human recombinant S1P4 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
    Activity at human recombinant S1P4 receptor expressed in CHO cells assessed as increase in calcium release by FLIPR assay
    [PMID: 17070046]
    CHO IC50
    0.04 nM
    Compound: S1P
    Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
    Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
    [PMID: 15149705]
    CHO IC50
    0.16 nM
    Compound: S1P
    Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 1 expressed on CHO cell membranes
    Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 1 expressed on CHO cell membranes
    [PMID: 15149705]
    CHO IC50
    0.23 nM
    Compound: S1P
    Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 5 expressed on CHO cell membranes
    Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 5 expressed on CHO cell membranes
    [PMID: 15149705]
    CHO IC50
    0.26 nM
    Compound: S1P
    Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
    Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
    [PMID: 15615513]
    CHO IC50
    0.35 nM
    Compound: S1P
    Displacement of [33P]sphingosine 1 phosphate from human S1P2 receptor expressed in CHO cells
    Displacement of [33P]sphingosine 1 phosphate from human S1P2 receptor expressed in CHO cells
    [PMID: 15615513]
    CHO IC50
    0.55 nM
    Compound: S1P
    Displacement of [33P]sphingosine 1 phosphate from human S1P5 receptor expressed in CHO cells
    Displacement of [33P]sphingosine 1 phosphate from human S1P5 receptor expressed in CHO cells
    [PMID: 15615513]
    CHO IC50
    0.67 nM
    Compound: S1P
    Displacement of [33P]sphingosine 1 phosphate from human S1P1 receptor expressed in CHO cells
    Displacement of [33P]sphingosine 1 phosphate from human S1P1 receptor expressed in CHO cells
    [PMID: 15615513]
    CHO IC50
    2.9 nM
    Compound: S1P
    Displacement of [33P]S1P from human recombinant S1P4 receptor expressed in CHO cells by scintillation counting
    Displacement of [33P]S1P from human recombinant S1P4 receptor expressed in CHO cells by scintillation counting
    [PMID: 20446681]
    CHO IC50
    23 nM
    Compound: S1P
    Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 4 expressed on CHO cell membranes
    Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 4 expressed on CHO cell membranes
    [PMID: 15149705]
    CHO IC50
    34 nM
    Compound: S1P
    Displacement of [33P]sphingosine 1 phosphate from human S1P4 receptor expressed in CHO cells
    Displacement of [33P]sphingosine 1 phosphate from human S1P4 receptor expressed in CHO cells
    [PMID: 15615513]
    HEK-293T EC50
    0.9 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
    [PMID: 14505636]
    HEK-293T EC50
    1.1 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
    [PMID: 14505636]
    HEK-293T EC50
    1.2 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
    [PMID: 15341948]
    HEK-293T EC50
    1.3 nM
    Compound: S1P
    Agonist activity at human S1P2R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
    Agonist activity at human S1P2R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
    [PMID: 24900589]
    HEK-293T EC50
    1.7 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
    [PMID: 15341948]
    HEK-293T EC50
    1.8 nM
    Compound: S1P
    Agonist activity at human S1P5R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
    Agonist activity at human S1P5R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
    [PMID: 24900589]
    HEK-293T EC50
    13 nM
    Compound: S1P
    Agonist activity at human S1P4R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
    Agonist activity at human S1P4R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
    [PMID: 24900589]
    HEK-293T EC50
    2.2 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 2 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 2 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
    [PMID: 15341948]
    HEK-293T EC50
    2.4 nM
    Compound: S1P
    Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
    Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
    [PMID: 20304639]
    HEK-293T EC50
    2.4 nM
    Compound: S1P
    Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
    Agonist activity at human S1P3 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
    [PMID: 23245510]
    HEK-293T EC50
    2.9 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 2 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 2 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
    [PMID: 14505636]
    HEK-293T EC50
    20 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
    [PMID: 15341948]
    HEK-293T EC50
    270 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 4 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 4 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
    [PMID: 14505636]
    HEK-293T EC50
    3.94 nM
    Compound: S1P
    Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
    Agonist activity at human S1P3R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
    [PMID: 24900589]
    HEK-293T EC50
    37 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 4 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 4 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
    [PMID: 15341948]
    HEK-293T EC50
    4.25 nM
    Compound: S1P
    Agonist activity at human S1P1R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
    Agonist activity at human S1P1R expressed in HEK293T cells assessed as [35S]GTPgammaS binding after 30 mins by scintillation counting
    [PMID: 24900589]
    HEK-293T EC50
    4.5 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand. (Experiment 2)
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand. (Experiment 2)
    [PMID: 14505636]
    HEK-293T EC50
    43.9 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
    [PMID: 14505636]
    HEK-293T EC50
    5.6 nM
    Compound: S1P
    Antagonist activity at human S1P1 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
    Antagonist activity at human S1P1 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
    [PMID: 20304639]
    HEK-293T EC50
    5.6 nM
    Compound: S1P
    Agonist activity at human S1P1 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
    Agonist activity at human S1P1 receptor expressed in HEK293T cells assessed as stimulation of [35S]GTPgammaS binding
    [PMID: 23245510]
    HEK-293T EC50
    8.3 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 2 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 2 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
    [PMID: 14505636]
    HEK-293T EC50
    8.7 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
    [PMID: 14505636]
    HEK-293T EC50
    9.2 nM
    Compound: S1P
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
    In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
    [PMID: 14505636]
    HEK-293T EC50
    4.5 x 10-9 M
    Compound: 1 (S1P)
    Effective concentration required for [35S]GTP-gamma-S binding towards Sphingosine 1-phosphate receptor G-protein complex expressed in HEK293T cells
    Effective concentration required for [35S]GTP-gamma-S binding towards Sphingosine 1-phosphate receptor G-protein complex expressed in HEK293T cells
    [PMID: 16125386]
    HEK-293T EC50
    8.3 x 10-9 M
    Compound: 1 (S1P)
    Effective concentration required for [35S]GTP-gamma-S binding towards Sphingosine 1-phosphate receptor G-protein complex expressed in HEK293T cells
    Effective concentration required for [35S]GTP-gamma-S binding towards Sphingosine 1-phosphate receptor G-protein complex expressed in HEK293T cells
    [PMID: 16125386]
    HEK-293T EC50
    8.7 x 10-9 M
    Compound: 1 (S1P)
    Effective concentration required for [35S]GTP-gamma-S binding towards Sphingosine 1-phosphate receptor G-protein complex expressed in HEK293T cells
    Effective concentration required for [35S]GTP-gamma-S binding towards Sphingosine 1-phosphate receptor G-protein complex expressed in HEK293T cells
    [PMID: 16125386]
    HEK-293T EC50
    2.7 x 10-9 M
    Compound: 1 (S1P)
    Effective concentration required for [35S]GTP-gamma-S binding towards Sphingosine 1-phosphate receptor G-protein complex expressed in HEK293T cells
    Effective concentration required for [35S]GTP-gamma-S binding towards Sphingosine 1-phosphate receptor G-protein complex expressed in HEK293T cells
    [PMID: 16125386]
    HEK-293T EC50
    9.2 x 10-9 M
    Compound: 1 (S1P)
    Effective concentration required for [35S]GTP-gamma-S binding towards Sphingosine 1-phosphate receptor G-protein complex expressed in HEK293T cells
    Effective concentration required for [35S]GTP-gamma-S binding towards Sphingosine 1-phosphate receptor G-protein complex expressed in HEK293T cells
    [PMID: 16125386]
    HEK-293T IC50
    0.78 nM
    Compound: S1P
    Displacement of [33P]sphingosine-1-phosphate from human S1P1 receptor expressed in HEK293T cells after 60 mins by scintillation counting
    Displacement of [33P]sphingosine-1-phosphate from human S1P1 receptor expressed in HEK293T cells after 60 mins by scintillation counting
    [PMID: 20304639]
    HEK-293T IC50
    0.92 nM
    Compound: S1P
    Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
    Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
    [PMID: 20304639]
    HEK-293T IC50
    1.04 nM
    Compound: S1P
    Displacement of [33P]sphingosine-1-phosphate from human S1P4 receptor expressed in HEK293T cells after 60 mins by scintillation counting
    Displacement of [33P]sphingosine-1-phosphate from human S1P4 receptor expressed in HEK293T cells after 60 mins by scintillation counting
    [PMID: 20304639]
    HEK-293T IC50
    2 nM
    Compound: S1P
    Displacement of [33P]sphingosine-1-phosphate from human S1P5 receptor expressed in HEK293T cells after 60 mins by scintillation counting
    Displacement of [33P]sphingosine-1-phosphate from human S1P5 receptor expressed in HEK293T cells after 60 mins by scintillation counting
    [PMID: 20304639]
    HEK293 EC50
    0.1 nM
    Compound: S1P
    Displacement of [33P]S1P from human recombinant S1P1 receptor expressed in HEK cells by scintillation counting
    Displacement of [33P]S1P from human recombinant S1P1 receptor expressed in HEK cells by scintillation counting
    [PMID: 20446681]
    HEK293 EC50
    0.2 nM
    Compound: S1P
    Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
    Displacement of [33P]S1P from human recombinant S1P3 receptor expressed in HEK cells by scintillation counting
    [PMID: 20446681]
    HEK293 EC50
    0.7 nM
    Compound: S1P
    Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
    Agonist activity at human recombinant S1P3 receptor expressed in HEK cells by GTPgammaS binding assay
    [PMID: 20446681]
    HEK293 EC50
    0.7 nM
    Compound: S1P
    Displacement of [33P]S1P from human recombinant S1P2 receptor expressed in HEK cells by scintillation counting
    Displacement of [33P]S1P from human recombinant S1P2 receptor expressed in HEK cells by scintillation counting
    [PMID: 20446681]
    HEK293 EC50
    25.3 nM
    Compound: S1P
    Agonist activity at human recombinant S1P1 receptor expressed in HEK cells by GTPgammaS binding assay
    Agonist activity at human recombinant S1P1 receptor expressed in HEK cells by GTPgammaS binding assay
    [PMID: 20446681]
    HEK293 EC50
    43.9 nM
    Compound: S1P
    Agonist activity at human recombinant S1P2 receptor expressed in HEK cells by GTPgammaS binding assay
    Agonist activity at human recombinant S1P2 receptor expressed in HEK cells by GTPgammaS binding assay
    [PMID: 20446681]
    U2OS EC50
    0.018 μM
    Compound: 1, S1P
    Agonist activity at human S1P1 receptor expressed in human U2OS cells co-expressing eGFP assessed as receptor internalization into cytoplasm using Hoechst dye staining
    Agonist activity at human S1P1 receptor expressed in human U2OS cells co-expressing eGFP assessed as receptor internalization into cytoplasm using Hoechst dye staining
    [PMID: 22104144]
    U2OS EC50
    2.8 nM
    Compound: S1P
    Agonist activity at human S1P1 receptor expressed in EDG1-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
    Agonist activity at human S1P1 receptor expressed in EDG1-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
    [PMID: 26687487]
    U2OS EC50
    79 nM
    Compound: S1P
    Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
    Agonist activity at human S1P3 receptor expressed in EDG3-bla U2OS cells incubated for 18 hrs prior to GenBlazer substrate addition by beta-arrestin recruitment assay
    [PMID: 26687487]
    In Vitro

    S1P (1 μM) induces a significant Ca2+ releases in HEK293 cells under serum starvation conditions (1% FCS)[1].
    In a functional Ca2+ assay, Suramin (HY-B0879) alone does not exert any effect on intracellular Ca2+ release via gpr3, gpr6 or gpr12. In contrast, S1P (1 μM) induces Ca2+ release of gpr3, gpr6 and gpr12 in the presence of Suramin (HY-B0879) various concentrations in transfected HEK293 cells[2].
    In a functional Ca2+ assay,S1P (3-3000 nM) in the presence Suramin (300 μM), exhibits nanomolar EC50 values for gpr3 (EC50=29 nM), gpr6 (EC50=15 nM) and gpr12 (EC50=24 nM), rat gpr3 (EC50=68 nM),respectively in HEK293 cells[2].
    S1P increases intracellular calcium levels in TAg-Jurkat cells expressing S1P1 and Gqi5, which allows for phospholipase C stimulation by Gi proteins, when used at a concentration of 200 nM, as well as in TAg-Jurkat cells expressing S1P2 and S1P3 receptors (EC50s = 8 and 11 nM, respectively)[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    Molecular Weight

    379.47

    Formula

    C18H38NO5P

    CAS No.
    Appearance

    Solid

    Color

    White to yellow

    SMILES

    N[C@@H](CO[P](O)(O)=O)[C@H](O)/C=C/CCCCCCCCCCCCC

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    -20°C, sealed storage, away from moisture

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    Solvent & Solubility
    In Vitro: 

    Methanol : 3.85 mg/mL (10.15 mM; ultrasonic and warming and adjust pH to 3 with 1M HCl and heat to 60°C)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.6353 mL 13.1763 mL 26.3525 mL
    5 mM 0.5271 mL 2.6353 mL 5.2705 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  0.1% BSA in Saline

      Solubility: 0.5 mg/mL (1.32 mM); Suspended solution; Need ultrasonic and warming and heat to 60°C

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    Purity & Documentation

    Purity: 99.69%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    Methanol 1 mM 2.6353 mL 13.1763 mL 26.3525 mL 65.8814 mL
    5 mM 0.5271 mL 2.6353 mL 5.2705 mL 13.1763 mL
    10 mM 0.2635 mL 1.3176 mL 2.6353 mL 6.5881 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Sphingosine-1-phosphate
    Cat. No.:
    HY-108496
    Quantity:
    MCE Japan Authorized Agent: